Drug-labels.com

Td Adsorbed: Uses, Side Effects and Dosage

Updated:
Strength:
2 LF / 5 LF

Patient Medication Information: uses, side effects, how to take - Td Adsorbed

What is Td ADSORBED used for?

Td ADSORBED is a vaccine that is used to boost the body’s protection against tetanus and diphtheria. This vaccine may be given to persons 7 years of age and older.

The majority of persons who are vaccinated with Td ADSORBED will produce enough antibodies to protect them against these diseases. However, as with all vaccines, 100% protection cannot be guaranteed.

How does Td ADSORBED work?

Td ADSORBED causes your body to produce its own natural protection against tetanus and diphtheria. After you receive the vaccine, your body begins to make substances called antibodies. Antibodies help your body to fight disease. If a vaccinated person comes into contact with one of the germs that cause these diseases, the body is usually ready to destroy it.

What are the ingredients in Td ADSORBED?

Each 0.5 mL dose of Td ADSORBED contains:

Medicinal ingredients: tetanus toxoid and diphtheria toxoid.

Non-medicinal ingredients:

Td Adsorbed with 2-phenoxyethanol (not as a preservative):

Aluminum phosphate, 2-phenoxyethanol, isotonic solution of sodium chloride in water for injection. Residual formaldehyde is present in trace amounts.

Td Adsorbed without 2-phenoxyethanol :

Aluminum phosphate, saline and water for injection. Residual formaldehyde is present in trace amounts.

Td ADSORBED comes in the following dosage forms:

Td ADSORBED is a liquid vaccine that is injected into a muscle. A single dose is 0.5 mL.

Do not use Td ADSORBED if:

  • persons who are known to have a severe allergy to any ingredient in the vaccine or its container, or who have had a severe allergic reaction after receiving a vaccine that contained similar ingredients.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Td ADSORBED. Talk about any health conditions or problems you may have including:

  • A high fever or serious illness. Delay the vaccination until the person is better.
  • An allergy to any component of the vaccine or the container.
  • A serious nervous system adverse event following a previous tetanus vaccination.
  • Pregnant or nursing mothers. It is important that you understand the risks and benefits of vaccination. Td ADSORBED should be given to a pregnant woman only if it is clearly needed. Tell the person giving you the injection if you are pregnant or breast-feeding.

  • A weakened immune system. The vaccine may provide you with a lower level of protection than it does for people with healthy immune systems. If possible, try to postpone the vaccination until after you have completed the treatment that affects your immune system.
  • A bleeding disorder or taking blood-thinning medications. Tell the person giving you the injection about your condition. The injection must be done carefully to prevent excessive bleeding.
  • Fainting can occur following, or even before, any needle injection. Therefore, tell your doctor or nurse if your child fainted with a previous injection.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with Td ADSORBED:

  • DO NOT mix Td ADSORBED with other vaccines or medicinal products in the same syringe.

How to take Td ADSORBED :

Usual dose:

Td ADSORBED may be used for primary and booster vaccination.

The vaccination should be given in the muscle, preferably in the deltoid (shoulder) region.

Primary Immunization

A series of three (0.5 mL) doses is required for the primary immunization of persons 7 years of age and older. The first two doses should be given 4 to 8 weeks apart and the third dose 6 to 12 months later.

A delay between doses should not interfere with the final immunity achieved with Td ADSORBED. There is no need to start the series over, regardless of the time elapsed between doses.

Booster Immunization

A single (0.5 mL) dose is required for booster immunization of persons 7 years of age and older.

For persons who have previously been immunized against tetanus and diphtheria, a dose of 0.5 mL should be administered as a reinforcing dose at approximately 10 year intervals.

Overdose:

If you think you, or a person you are caring for, have taken too much Td ADSORBED, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

Not applicable for this vaccine.

What are possible side effects from using Td ADSORBED?

These are not all the possible side effects you may have when taking Td ADSORBED. If you experience any side effects not listed here, tell your healthcare professional.

A vaccine, like any medicine, may cause serious problems, such as severe allergic reactions. The risk of Td ADSORBED causing serious harm is extremely small. The small risks associated with Td ADSORBED are much less than the risks associated with getting the diseases.

Tell your doctor, nurse or pharmacist as soon as possible if you do not feel well after receiving Td ADSORBED.

Serious side effects are extremely rare.

Some people who receive Td ADSORBED may have mild side effects such as pain, swelling and redness at the injection site. These side effects usually go away within a few days.

Serious side effects and what to do about them
Symptom / effectTalk to your healthcare professional
Only if severeIn all cases

Allergic reactions including Anaphylaxis/Anaphylactic reactions

urticaria and oedema of the mouth

✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Suspected Side Effects for Vaccines

For the general public: Should you experience a side effect following immunization, please report it to your healthcare professional.

Should you require information related to the management of the side effect, please contact your healthcare professional. The Public Health Agency of Canada, Health Canada and Sanofi Pasteur cannot provide medical advice.

For healthcare professionals: If a patient experiences a side effect following immunization, please complete the Adverse Events Following Immunization (AEFI) Form appropriate for your province/territory (http://www.phac-aspc.gc.ca/im/aefi-essi-form-eng.php) and send it to your local Health Unit.

Storage:

Store the vaccine in a refrigerator at 2° to 8°C (35° to 46°F). Do not freeze. Throw the product away if it has been exposed to freezing.

Do not use after the expiration date.

Keep out of reach and sight of children.

If you want more information about Td ADSORBED:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the Sanofi Canada website ( https://www.sanofi.com/en/canada) or by calling the vaccine producer at 1-888-621-1146 (no charge).

Last Revised: 2026-04-20

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02528401

Revision date stated in the text: April 20, 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Td Adsorbed

DIN 02528401, 00514462
Schedule(s) SCHEDULE D
Active ingredient(s) Diphtheria toxoid adsorbed 2 LF, Tetanus toxoid adsorbed 5 LF
Dosage form(s) Suspension
Route(s) of administration Intramuscular
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J07 Vaccines
      1. J07A Bacterial vaccines
        1. J07AM Tetanus vaccines
          1. J07AM51 Tetanus toxoid, comb. with diphtheria toxoid
Company SANOFI VACCINES CANADA LTD.
Strengths and forms
DIN Strength Dosage form(s) Current status
02528401 2 LF / 5 LF Suspension Marketed April 9, 2024
00514462 2 LF / 5 LF Suspension Cancelled Post Market October 31, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.